TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26950418

Group type: EXPERIMENTAL
Intervention: Seven-point BG testing before and after each meal and at bedtime over a course of 3 days in 1 month (n=40)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Six-pair glucose test of pre- and postprandial BG per week (n=43)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Three-pair glucose test of pre- and postprandial BG per week (n=39)
Number of subjects: 138
Study: 24143910

Group type: EXPERIMENTAL
Intervention: Multipurpose contact lens solution/silicone hydrogel lens combination (renu® fresh™ and balafilcon A)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hydrogen peroxide care system (Clear Care®)
Number of subjects: 8
Study: 23268177

Group type: EXPERIMENTAL
Intervention: Hydrodynamic irrigation with 3% sodium hypochlorite (47 patients)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Hydrodynamic irrigation with laser root canal therapy (number of patients not specified)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Conventional root canal treatment (51 patients)
Number of subjects: 143
Study: 19514448

Group type: EXPERIMENTAL
Intervention: Vobenzyme added to standard antibiotic therapy
Number of subjects: 60
Study: 17623763

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (FAC protocol: 5-fluorouracil, adriamycin, and cyclophosphamide)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC protocol: adriamycin and cyclophosphamide)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (CMF protocol: cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All chemotherapy protocols
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy women (control group)
Number of subjects: 30
Study: 15756498

Group type: EXPERIMENTAL
Intervention: (18)F-FDG-PET
Number of subjects: 9
Study: 12009222

Group type: EXPERIMENTAL
Intervention: Conventional CPR instruction
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Re-training
Number of subjects: 262
Study: 10658309

Group type: EXPERIMENTAL
Intervention: Low-intensity nutrition intervention including individualized health risk appraisal, group sessions, mass media activities, and environmental changes.
Number of subjects: 770

Group type: EXPERIMENTAL
Intervention: Low-intensity nutrition intervention
Number of subjects: 770

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 770
Study: 1319870

Group type: EXPERIMENTAL
Intervention: Crushed tablet with enteral feeding solution (Osmolite 100 ml/h started 2h before administration and continued for 4h postdose)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Crushed tablet without enteral feeding solution
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral tablet (reference)
Number of subjects: 18
Study: 6369956

Group type: EXPERIMENTAL
Intervention: Fructose diet
Number of subjects: 11
Study: 31442241

Group type: EXPERIMENTAL
Intervention: eHealth intervention
Number of subjects: 715

Group type: COMPARATOR
Intervention: Control
Number of subjects: 715
Study: 29396806

Group type: EXPERIMENTAL
Intervention: Flexion group (knee at 90° flexion for 12 hours, then 60° for 12 hours, combined with 1g TXA topical and 1g TXA intravenous)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Extension group (knee in full extension, combined with topical and intravenous TXA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Controlled group (knee in full extension, combined with single intravenous TXA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Flexion group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Extension group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Controlled group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 26778246

Group type: EXPERIMENTAL
Intervention: Propeller Health system (Intervention Group - IG)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Routine care (Control Group - RC)
Number of subjects: 495
Study: 25676423

Group type: EXPERIMENTAL
Intervention: Sapacitabine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC)
Number of subjects: 143
Study: 23772997

Group type: EXPERIMENTAL
Intervention: Bath PUVA
Number of subjects: 74

Group type: COMPARATOR
Intervention: System PUVA
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 74
Study: 20572403

Group type: EXPERIMENTAL
Intervention: Guided imagery (28 minutes of listening to a guided imagery CD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study: 19007042

Group type: EXPERIMENTAL
Intervention: lamivudine (150 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: stavudine (40 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: nevirapine (200 mg)
Number of subjects: 18
Study: 16614435

Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folic acid and iron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folic acid, iron, and zinc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement with vitamin A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Vitamin A alone)
Number of subjects: 0
Study: 12664066

Group type: EXPERIMENTAL
Intervention: Local injection of lidocaine in the periprostatic nerves
Number of subjects: 60

Group type: COMPARATOR
Intervention: No anesthetic (Control)
Number of subjects: 60
Study: 10857841

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) adjunctive treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (trabeculectomy alone)
Number of subjects: 52
Study: 9094916

Group type: EXPERIMENTAL
Intervention: 24-hour dietary recall method
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3-day weighed-food records
Number of subjects: 0
Study: 8511730

Group type: EXPERIMENTAL
Intervention: Active ioniser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo ioniser
Number of subjects: 20
Study: 3667021

Group type: EXPERIMENTAL
Intervention: Electrical stimulation at low frequency (50 Hz)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electrical stimulation at high frequency (2000 Hz)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 36
Study: 30687550

Group type: EXPERIMENTAL
Intervention: Dinner meal replacement (388 kcal)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (routine diet)
Number of subjects: 174
Study: 27271265

Group type: EXPERIMENTAL
Intervention: Plant-based emollient (G1)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Petrolatum-based emollient (G2)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Plant-based emollient (G3)
Number of subjects: 43
Study: 24950759

Group type: EXPERIMENTAL
Intervention: Peer counselling for exclusive breastfeeding (EBF)
Number of subjects: 2579

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2579
Study: 22544914

Group type: EXPERIMENTAL
Intervention: Fructose-sweetened beverage (FB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Glucose beverage (GB)
Number of subjects: 19
Study: 20149929

Group type: EXPERIMENTAL
Intervention: Incremental bicycle test in depressed patients
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Strength training intervention in depressed patients
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Resting hormonal levels in depressed patients
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: PRL response to acute exercise in depressed patients
Number of subjects: 137
Study: 18672990

Group type: EXPERIMENTAL
Intervention: Subantimicrobial-dose doxycycline (SDD)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 15679793

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 12696088

Group type: EXPERIMENTAL
Intervention: 902 MHz electromagnetic field (EMF) on
Number of subjects: 64

Group type: COMPARATOR
Intervention: 902 MHz electromagnetic field (EMF) off
Number of subjects: 64
Study: 10596677

Group type: EXPERIMENTAL
Intervention: Filgrastim (recombinant methionyl human granulocyte colony-stimulating factor)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 258
Study: 8967667

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone, 0.1 mg/kg of body weight per day (average dosage, 6 mg/d) for 12 weeks
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178

Group type: COMPARATOR
Intervention: Recombinant human growth hormone and Placebo
Number of subjects: 178
Study: 1653773

Group type: EXPERIMENTAL
Intervention: BW 91Y (3‐deazaadenosine) at 600 pg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BW 91Y (3‐deazaadenosine)
Number of subjects: 0
Study: 6142508

Group type: EXPERIMENTAL
Intervention: Oral almitrine 200 mg/day
Number of subjects: 9
Study: 30839430

Group type: EXPERIMENTAL
Intervention: Loxoprofen sodium topical patch (LX-P)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Loxoprofen tablet (LX-T)
Number of subjects: 242
Study: 28679073

Group type: EXPERIMENTAL
Intervention: Cancer Carers Medicines Management (CCMM)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nurse-delivered structured conversational process
Number of subjects: 57
Study: 26551528

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 115

Group type: COMPARATOR
Intervention: No oil
Number of subjects: 115
Study: 25211703

Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (150 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 22356705

Group type: EXPERIMENTAL
Intervention: 20 ml of neutral 0.025% sodium fluoride rinse (group II)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tooth mousse twice a day in addition to fluoride toothpaste for 6 months (group III)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Microabrasion technique (group IV)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Brushing teeth only (control group I)
Number of subjects: 80
Study: 19652851

Group type: EXPERIMENTAL
Intervention: External Fixation (EF)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Open Reduction Internal Fixation (ORIF) with plates and screws
Number of subjects: 35
Study: 17080442

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MP) 0.25 mg/kg
Number of subjects: 7
Study: 15219473

Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 21
Study: 11829722

Group type: EXPERIMENTAL
Intervention: Salvage antiretroviral therapy (specific agents not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance testing and pharmacokinetic interactions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New agents and new classes of drugs in salvage therapy
Number of subjects: 0
Study: 9810992

Group type: EXPERIMENTAL
Intervention: Silicone occlusive sheeting (Sil-K) used in 68 patients
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Silicone occlusive gel (Epiderm) used in 61 patients
Number of subjects: 129

Group type: COMPARATOR
Intervention: Micropore (control group)
Number of subjects: 129
Study: 7653448

Group type: EXPERIMENTAL
Intervention: Pravastatin/Niacin
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Pravastatin/Magnesium
Number of subjects: 65

Group type: COMPARATOR
Intervention: Pravastatin/Placebo
Number of subjects: 65
Study: 2648927

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (32 mg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 1103271

Group type: EXPERIMENTAL
Intervention: Diphenoxylate 5 mg three times daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30738047

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 499
Study: 27887804

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: PBM + Physiotherapy (PT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 70
Study: 25257157

Group type: EXPERIMENTAL
Intervention: Stronger Kurdish identity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stronger common ingroup identity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structural disadvantage
Number of subjects: 0
Study: 24552358

Group type: EXPERIMENTAL
Intervention: fesoterodine 8 mg
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1955

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1955
Study: 21609340

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (DDD)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Atrial synchronous pacing (VDD)
Number of subjects: 19
Study: 18551007

Group type: EXPERIMENTAL
Intervention: Short-term repeatability of morning blood pressure measurements
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Long-term repeatability of morning blood pressure measurements
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Categorical analysis of short-term repeatability of morning surge
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Categorical analysis of long-term repeatability of morning surge
Number of subjects: 173
Study: 16522387

Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry + cardiotocograph monitoring
Number of subjects: 600

Group type: COMPARATOR
Intervention: Cardiotocograph-only monitoring
Number of subjects: 600
Study: 14527904

Group type: EXPERIMENTAL
Intervention: Calcium chemoprevention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 220
Study: 11228945

Group type: EXPERIMENTAL
Intervention: Partial Body Weight-Supported Treadmill Training (PBWSTT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Aggressive Bracing Assisted Walking (ABAW)
Number of subjects: 56
Study: 8838189

Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC) at 1.2-5.0 mg/(kg.d) for 6 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Amphotericin B (AmB) at 0.7-1.2 mg/(kg.d) for 6 weeks
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Amphotericin B lipid complex (ABLC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Amphotericin B (AmB)
Number of subjects: 55
Study: 1457695

Group type: COMPARATOR
Intervention: Low flux hemodialysis (cuprophane)
Number of subjects: 32

Group type: COMPARATOR
Intervention: High flux hemodialysis (polysulfone)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hemofiltration (high flux polysulfone)
Number of subjects: 32
Study: 6656341

Group type: EXPERIMENTAL
Intervention: On-service housestaff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Off-service housestaff
Number of subjects: 0
Study: 30853454

Group type: EXPERIMENTAL
Intervention: Anterior approach (AA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior approach (PA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 100
Study: 28523988

Group type: EXPERIMENTAL
Intervention: Myofascial therapy (8 sessions from 2 to 4 months post-surgery)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard physical therapy programme
Number of subjects: 147
Study: 26502183

Group type: EXPERIMENTAL
Intervention: Parental counseling to increase children's physical activity (n = 46)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (n = 45)
Number of subjects: 91
Study: 24290656

Group type: EXPERIMENTAL
Intervention: BM‐MNC+HOT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BM‐MNC
Number of subjects: 80

Group type: COMPARATOR
Intervention: HOT
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 22965592

Group type: EXPERIMENTAL
Intervention: Outpatient low-vision rehabilitation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 100
Study: 19417018

Group type: EXPERIMENTAL
Intervention: docetaxel with bevacizumab (DB)
Number of subjects: 49

Group type: COMPARATOR
Intervention: docetaxel (D)
Number of subjects: 49
Study: 17462117

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 24
Study: 15899921

Group type: EXPERIMENTAL
Intervention: Developmental education programme
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 284

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 284
Study: 12645187

Group type: EXPERIMENTAL
Intervention: Low flow supplemental oxygen therapy
Number of subjects: 26
Study: 9594864

Group type: EXPERIMENTAL
Intervention: SMA group (n = 10) - CPB circuit treated with surface-modifying additive (SMA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 10) - CPB circuit without treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 7542804

Group type: EXPERIMENTAL
Intervention: AZT-3TC combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: AZT alone
Number of subjects: 0
Study: 2466351

Group type: EXPERIMENTAL
Intervention: Hypervolemic hemodilution (HH) with pentastarch
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard therapy (S)
Number of subjects: 88
Study: 80528

Group type: EXPERIMENTAL
Intervention: Cephalothin and gentamicin (C.G.)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cephalothin and tobramycin (C.T.)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Methicillin and gentamicin (M.G.)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Methicillin and tobramycin (M.T.)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined cephalothin groups (C.G. and C.T.)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Combined methicillin groups (M.G. and M.T.)
Number of subjects: 90
Study: 31345981

Group type: EXPERIMENTAL
Intervention: Culture-specific, barbershop-based intervention targeting masculinity barriers to care and CRC-screening uptake.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Masculinity Barriers to Care Scale (MBCS) administered as an online quantitative survey.
Number of subjects: 0
Study: 28678383

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg every 2 weeks)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Bevacizumab plus carboplatin
Number of subjects: 122
Study: 26243685

Group type: EXPERIMENTAL
Intervention: Videoteleconferencing (VTC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: In-person (NP)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Both conditions pooled together
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Veterans (VTC and NP combined)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Civilians (VTC and NP combined)
Number of subjects: 126
Study: 23883616

Group type: EXPERIMENTAL
Intervention: Unitcheck (Web-based personalized feedback intervention)
Number of subjects: 1478

Group type: COMPARATOR
Intervention: Control (assessment only)
Number of subjects: 1478
Study: 21277394

Group type: EXPERIMENTAL
Intervention: Budesonide (0.25 mg twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 28
Study: 19799571

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) system with varying call schedules (weekly, biweekly, monthly)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IVR system
Number of subjects: 95
Study: 17433399

Group type: EXPERIMENTAL
Intervention: Preview condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-set baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Old distractor group differing in orientation from new distractors
Number of subjects: 0
Study: 15696287

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of dilute lidocaine (40 mg in 6.0 ml, 3.0 ml for each side or 4.0 and 2.0 ml for two sides)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline solution (6.0 ml) as a placebo
Number of subjects: 46
Study: 12475460

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (CEE), 0.625 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.1 mg/day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral CEE
Number of subjects: 38
Study: 9808096

Group type: EXPERIMENTAL
Intervention: Dihydropyridine calcium channel blockers (CCB)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: COMPARATOR
Intervention: ACEI
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: CCB with ACEI
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 117

Group type: COMPARATOR
Intervention: CCB and placebo
Number of subjects: 117
Study: 7711819

Group type: EXPERIMENTAL
Intervention: Environmental intervention
Number of subjects: 0
Study: 2618921

Group type: EXPERIMENTAL
Intervention: Self‐Instructional Parent Program (SIPP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No program (Control group)
Number of subjects: 50
Study: 722270

Group type: EXPERIMENTAL
Intervention: Family Practice Group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Family Planning Clinics Group
Number of subjects: 240
Study: 31377901

Group type: EXPERIMENTAL
Intervention: Adenotonsillotomy (ATT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Adenotonsillectomy (ATE)
Number of subjects: 79
Study: 28910185

Group type: EXPERIMENTAL
Intervention: Art therapy intervention for smoking cessation over six weeks.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Typical courses on smoking cessation (comparison group).
Number of subjects: 66
Study: 26836732

Group type: EXPERIMENTAL
Intervention: Expiratory central airway collapse (ECAC)
Number of subjects: 8820
Study: 25347451

Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (24 U)
Number of subjects: 445

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 445